| Ytd | -75.63% | |
| 1y | -86.79% |
| Open | 5.33 | Prev Close | 4.75 | Low | 4.84 | High | 5.50 | Mkt Cap | 9.26M |
| Vol | 185.10K | Avg Vol | 167.87K | EPS | -1.57 | P/E | -3.03 | Forward P/E | -0.77 |
| Beta | 3.08 | Short Ratio | 3.96 | Inst. Own | 24.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 8.15 | 200-d Avg | 17.66 | 1yr Est | 21.00 |
CRIS News
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
Updated Clinical Data in PCNSL Increased Guidance on Year-End Data in CLL Company to Host Webcast at
Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, E
On June 26, 2026, Curis announced that eleven clinical sites had opened for enrollment in the TakeAi
LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company f
Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stoc
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ
Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance
Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-494
Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company
Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'
Curis, Inc. (CRIS) Q1 2026 Earnings Call Transcript
Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.
LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company fo
Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per shar
Curis (CRIS) might move higher on growing optimism about its earnings prospects, which is reflected
Curis, Inc. (CRIS) Q4 2025 Earnings Call Transcript
Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.
INGOLSTADT, Germany--(BUSINESS WIRE)--SecurityBridge, a leading provider of cybersecurity solutions
LEXINGTON, Mass., March 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company
eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-
Led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, LLC, and The Red Hook
LEXINGTON, Mass., Jan. 7, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company f
5 of 8 patients (62.5%) achieved Undetectable MRD (uMRD) LEXINGTON, Mass. , Dec. 9, 2025 /PRNewswire
LEXINGTON, Mass. , Nov. 14, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company
Curis, Inc. ( CRIS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Diantha
Curis (CRIS) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate o
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
On Friday, 431 companies hit new 52-week lows.
On Monday, 147 stocks hit new 52-week lows.
On Thursday, 112 stocks made new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e